116 related articles for article (PubMed ID: 34694788)
21. Comment on physical activity.
Tsakok AD
J Clin Epidemiol; 1997 May; 50(5):631. PubMed ID: 9180657
[No Abstract] [Full Text] [Related]
22. Healthy worker survivor bias: implications of truncating follow-up at employment termination.
Picciotto S; Brown DM; Chevrier J; Eisen EA
Occup Environ Med; 2013 Oct; 70(10):736-42. PubMed ID: 23873985
[TBL] [Abstract][Full Text] [Related]
23. Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
Brooks MB; Mitnick CD; Manjourides J
PLoS One; 2020; 15(10):e0240297. PubMed ID: 33075072
[TBL] [Abstract][Full Text] [Related]
24. A Systematic Comparison of Designs to Study Human Fecundity.
Eijkemans MJC; Leridon H; Keiding N; Slama R
Epidemiology; 2019 Jan; 30(1):120-129. PubMed ID: 30198936
[TBL] [Abstract][Full Text] [Related]
25. Construction of a survival tree for dependent censoring.
Shimokawa A; Miyaoka E
J Biopharm Stat; 2021 Jan; 31(1):63-78. PubMed ID: 32684123
[TBL] [Abstract][Full Text] [Related]
26. The FDA outlook of events reporting after ticagrelor or clopidogrel in the PLATO Trial: impact of sponsor censoring dates, drug discontinuation, and withdrawal of consent.
Serebruany VL
Cardiology; 2011; 120(3):169-71. PubMed ID: 22418766
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of left-censored quantitative outcome: example of procalcitonin level].
Asselineau J; Thiébaut R; Perez P; Pinganaud G; Chêne G
Rev Epidemiol Sante Publique; 2007 Jun; 55(3):213-20. PubMed ID: 17467942
[TBL] [Abstract][Full Text] [Related]
28. Survival forests for data with dependent censoring.
Moradian H; Larocque D; Bellavance F
Stat Methods Med Res; 2019 Feb; 28(2):445-461. PubMed ID: 28835170
[TBL] [Abstract][Full Text] [Related]
29. Another comment on the role of statistical methods.
Cox DR
Phys Ther; 2001 Aug; 81(8):1469. PubMed ID: 11512546
[No Abstract] [Full Text] [Related]
30. A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring.
Hubbard RA; Miglioretti DL
Biometrics; 2013 Mar; 69(1):245-53. PubMed ID: 23383717
[TBL] [Abstract][Full Text] [Related]
31. Censoring issues in survival analysis.
Leung KM; Elashoff RM; Afifi AA
Annu Rev Public Health; 1997; 18():83-104. PubMed ID: 9143713
[TBL] [Abstract][Full Text] [Related]
32. Applications of a parametric model for informative censoring.
Siannis F
Biometrics; 2004 Sep; 60(3):704-14. PubMed ID: 15339293
[TBL] [Abstract][Full Text] [Related]
33. Methodological considerations for developing and evaluating response bias indicators.
Burchett D; Ben-Porath YS
Psychol Assess; 2019 Dec; 31(12):1497-1511. PubMed ID: 31763874
[TBL] [Abstract][Full Text] [Related]
34. Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.
Cho Y; Hu C; Ghosh D
Stat Med; 2018 Feb; 37(3):390-404. PubMed ID: 29023972
[TBL] [Abstract][Full Text] [Related]
35. Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.
Gyawali B; de Vries EGE; Dafni U; Amaral T; Barriuso J; Bogaerts J; Calles A; Curigliano G; Gomez-Roca C; Kiesewetter B; Oosting S; Passaro A; Pentheroudakis G; Piccart M; Roitberg F; Tabernero J; Tarazona N; Trapani D; Wester R; Zarkavelis G; Zielinski C; Zygoura P; Cherny NI
ESMO Open; 2021 Jun; 6(3):100117. PubMed ID: 33887690
[TBL] [Abstract][Full Text] [Related]
36. Considerations for the design and analysis of experimental studies in physical activity and exercise promotion: advantages of the randomised controlled trial.
Tai SS; Iliffe S
Br J Sports Med; 2000 Jun; 34(3):220-4. PubMed ID: 10854027
[No Abstract] [Full Text] [Related]
37. Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.
Lok JJ; Yang S; Sharkey B; Hughes MD
Lifetime Data Anal; 2018 Apr; 24(2):201-223. PubMed ID: 28238045
[TBL] [Abstract][Full Text] [Related]
38. Methods comparison biases due to differing uncertainties and data censoring.
Sadler WA
Ann Clin Biochem; 2019 Sep; 56(5):608-612. PubMed ID: 31179711
[No Abstract] [Full Text] [Related]
39. Research participant compensation: A matter of statistical inference as well as ethics.
Swanson DM; Betensky RA
Contemp Clin Trials; 2015 Nov; 45(Pt B):265-269. PubMed ID: 26334678
[TBL] [Abstract][Full Text] [Related]
40. How is retrospective independent review influenced by investigator-introduced informative censoring: a quantitative approach.
Fleischer F; Gaschler-Markefski B; Bluhmki E
Stat Med; 2011 Dec; 30(29):3373-86. PubMed ID: 21953353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
